Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Pawlik Ww is active.

Publication


Featured researches published by Pawlik Ww.


Journal of Pineal Research | 2003

Protective effect of melatonin and its precursor L-tryptophan on acute pancreatitis induced by caerulein overstimulation or ischemia/reperfusion

Jolanta Jaworek; Anna Leja-Szpak; Bonior J; Katarzyna Nawrot; Tomaszewska R; Jerzy Stachura; Ryszard Sendur; Pawlik Ww; Tomasz Brzozowski; Stanislaw J. Konturek

Abstract: Melatonin, a pineal secretory product, synthesized from l‐tryptophan, has received increased attention because of its antioxidative and immunomodulatory properties. It has been detected in the gut and shown to protect the gastric mucosa, and liver from acute damage, but the role of melatonin in the protection of the pancreas against acute inflammation is not clear. The aim of this study was to investigate the effects of melatonin and its precursor, l‐tryptophan, on caerulein‐induced pancreatitis (CIP) and on ischemia/reperfusion (I/R)‐provoked pancreatitis in rats. CIP was induced by subcutaneous infusion of caerulein to the rats (25u2003μg/kg). I/R was induced by clamping of the inferior splenic artery for 30u2003min followed by 2 hr of reperfusion. Melatonin (10, 25 or 50 mg/hr) or l‐tryptophan (50, 100 or 250 mg/kg) was given as a bolus intraperitoneal (i.p.) injection 30 min prior to the onset of pancreatitis. CIP and I/R were confirmed by histologic examination and manifested by typical pancreatic edema, by an increase of plasma levels of amylase (by 500% in CIP and by 40% in I/R) and the pro‐inflammatory tumor necrosis factor α (TNFα) (by 500%). Lipid peroxidation products such as malondialdehyde (MDA) and 4‐hydroxynonenal (4‐HNE), were increased several fold in the pancreas CIP and I/R, whereas pancreatic blood flow (PBF) was significantly reduced in these animals. Pretreatment of rats subjected to CIP or to I/R with melatonin (25 or 50 mg/kg i.p.) or l‐tryptophan (100 or 250 mg/kg i.p.) significantly reduced pancreatic edema, plasma levels of amylase and TNFα and diminished pancreatic MDA + 4‐HNE contents, while enhancing PBF, pancreatic integrity and plasma levels of the anti‐inflammatory interleukin 10 (IL‐10). This was accompanied by a marked and dose‐dependent rise of plasma melatonin immunoreactivity. Gene expression of N‐acetyl transferase, an enzyme involved in melatonin biosynthesis, was detected in the pancreas of normal rats and was significantly enhanced in the rats with CIP. We conclude that exogenous melatonin, and that produced from l‐tryptophan, attenuates pancreatic damage induced by CIP or by I/R and this effect may be attributable to the reduction in lipid peroxidation and TNFα release combined with an increase of plasma anti‐inflammatory IL‐10 in rats with acute pancreatitis.


Digestion | 2000

Protective action of lipopolysaccharidesin rat caerulein-induced pancreatitis: role of nitric oxide.

Jolanta Jaworek; B. Jachimczak; R. Tomaszewska; Peter Ch Konturek; Pawlik Ww; R. Sendur; E. G. Hahn; J. Stachura; Konturek Sj

Lipopolysaccharides (LPS), the component of the cell wall of gram-negative bacteria, have been implicated in the pathogenesis of acute pancreatitis, but the mechanism of their action on the pancreas has not been fully explored. The aim of this study was to investigate the effects of various doses of LPS on the integrity of intact pancreas and that involved in acute caerulein-induced pancreatitis (CIP) in the rat and to compare these effects with those of nitric oxide (NO) donor, S-nitrose-acetylpenicillamine (SNAP). The expression of constitutive NO synthase (cNOS) and inducible NO synthase (iNOS) mRNA was also examined in the isolated pancreatic acini obtained from the inflamed pancreas of rats treated with LPS. CIP was produced by subcutaneous (s.c.) infusion of caerulein (5 μg/kg·h for 5 h) to conscious rats. Bolus injections of various doses of LPS (0.1, 1, 10, 20 or 40 mg/kg) or SNAP (1.5, 3 or 6 mg/kg) were made intraperitoneally (i.p.) either alone or 30 min prior to s.c. infusion of caerulein to induce CIP. Infusion of caerulein produced acute pancreatitis confirmed by histological examination and manifested by an increase of pancreatic mass (by about 200%). Blood levels of amylase and lipase were augmented by 400 and 800% respectively, whereas the pancreatic blood flow (PBF) was decreased by 50% in rats with CIP. Injection of low doses of LPS (0.1–1 mg/kg i.p.) or SNAP (1.5–3 mg/kg i.p.) 30 min prior to caerulein infusion reversed the harmful effects of pancreatic overstimulation with caerulein and reduced significantly the histological manifestations of CIP such as edema, neutrophil infiltration and vacuolization of the acinar cells. These protective effects of low doses of LPS pretreatment on the pancreas were completely antagonized by the suppression of the activity of NO synthase (NOS) with NG-nitro-L-arginine (L-NNA) applied (20 mg/kg i.p.) 15 min prior to the LPS injection. Combination of L-arginine (100 mg/kg i.p.), a substrate for NOS, with L-NNA given prior to low doses of LPS, restored the LPS-induced protection of the pancreas in rats with CIP. In contrast, higher doses of LPS (20–40 mg/kg i.p.) or SNAP (6 mg/kg i.p.), which produced a significant fall of the PBF, did not protect the pancreas against CIP. Administration of various doses of LPS to rats with CIP resulted in significant and dose-dependent stimulation of NO biosynthesis in the isolated acini obtained from the pancreas of these animals. LPS enhanced the expression of both cNOS and iNOS in the pancreatic acini obtained from rats subjected to CIP. The signal for cNOS mRNA was detected in all samples, reaching peak at the protective dose of LPS (1 mg/kg i.p.), while iNOS was overexpressed only at the highest doses of LPS that failed to exhibit the protective activity. We conclude that the pretreatment with low doses of LPS protects the pancreas against the damage provoked by CIP and this effect could be attributed, at least in part, to the activation of L-arginine-NO system in the pancreas.


Helicobacter | 2006

Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)-2 expression, apoptosis, and functional gastric mucosal impairment in Helicobacter pylori-infected Mongolian gerbils.

Tomasz Brzozowski; Peter C. Konturek; Marzena Mierzwa; Danuta Drozdowicz; Wladyslaw Bielanski; Kwiecień S; Stanislaw J. Konturek; Jerzy Stachura; Pawlik Ww; E. G. Hahn

Background:u2002 Helicobacter pylori infection in Mongolian gerbils is an established experimental model of gastric carcinogenesis that mimics H. pylori‐positive patients developing gastric ulcer and gastric cancer, but the effect of probiotic therapy on functional aspects of this infection remains unknown.


Scandinavian Journal of Gastroenterology | 2005

Influence of gastric colonization with Candida albicans on ulcer healing in rats: Effect of ranitidine, aspirin and probiotic therapy

Tomasz Brzozowski; Malgorzata Zwolinska-Wcislo; Peter C. Konturek; Kwiecień S; Danuta Drozdowicz; Stanislaw J. Konturek; Jerzy Stachura; Alicja Budak; Jozef Bogdal; Pawlik Ww; E. G. Hahn

Objective. Candida albicans frequently inhabits the gastrointestinal tract of humans leading to gastrointestinal candidiasis, especially following suppression of gastric acidity, but studies on the relation between this fungal infection and gastric pathology are limited due to lack of convenient animal models resembling Candida infection in humans. Material and methods. We compared the effects of C. albicans and vehicle inoculation on gastric secretion and healing of gastric ulcers induced by acetic acid in rats treated with 1) ranitidine (30 mg kg−1 day−1 s.c.) and 2) aspirin (ASA) (60 mg kg−1 day−1 i.g.) with or without probiotic bacteria Lactobacillus acidophillus. At day 0 and at 4, 15 and 25 days after ulcer induction, the ulcer area, the gastric blood flow (GBF), the quantitative gastric cultures of Candida and the expression of mRNAs for pro-inflammatory cytokines IL-1β and TNF-α and growth factors EGF and TGFα were assessed in the gastric mucosa. Results. Gastric acid output was reduced by over 40% soon after Candida inoculation and this effect persisted during all time intervals tested. The area of ulcers in control rats significantly decreased at day 15 and the ulcers disappeared almost completely after 25 days of their induction. In contrast, the ulcers were present until day 25 in Candida-inoculated rats followed by a fall in GBF and a rise in plasma gastrin levels, these effects being significantly attenuated by the co-treatment with Lactobacillus. Candidiasis was accompanied by up-regulation of mRNA for IL-1β, TNF-α, EGF and TGFα and a significant increment in plasma IL-1β and TNF-α levels. Conclusions. 1) Persistent colonization with Candida could be achieved in rats treated with antisecretory agents or non-steroidal anti-inflammatory drugs (NSAIDs) such as ASA; 2) candidiasis reduces gastric acid secretion, while delaying ulcer healing possibly due to the impairment in GBF in the ulcer area and enhanced expression and release of IL-1β and TNFα and 3) probiotic therapy could be useful in the treatment against the deleterious action of fungal infection on the healing of pre-existing gastric ulcers.


Digestion | 2003

Enhanced resistance of gastric mucosa to damaging agents in the rat stomach adapted to Helicobacter pylori lipopolysaccharide.

Tomasz Brzozowski; Peter C. Konturek; Anthony P. Moran; Kwiecień S; Robert Pajdo; Stanislaw J. Konturek; Danuta Drozdowicz; Agata Ptak; Pawlik Ww; E. G. Hahn

Background and Aim: Lipopolysaccharide (LPS) has been proposed to act as one of numerous virulence factors in the Helicobacter pylori (HP)-infected stomach. However, little is known as to whether the gastric mucosa can withstand the repeated LPS insult, and how the possible adaptation to this endotoxin influences the damage induced by strong irritants. We determined the effect of a single or repeated parenteral administration of LPS obtained from HP on acute gastric lesions induced by intragastric application of 100% ethanol (1.5 ml) and by water immersion and restraint stress (WRS). Methods: The area of the gastric lesions was measured by planimetry, mucosal gastric blood flow (GBF) was determined by H2 gas clearance, and gastric luminal content was collected for the determination of luminal NO2–/NO3– levels by the Griess reaction. Biopsy samples were taken for the measurement of prostaglandin (PG) E2 by radioimmunoassay and mucosal expression of constitutive and inducible nitric oxide synthase (cNOS and iNOS), constitutive (COX-1) and inducible cyclooxygenase (COX-2), heat shock protein 70 (HSP 70) mRNA and protein were analyzed by RT-PCR and Western blot. Results:HP LPS (1 mg/kg i.p.) injected once or 5 times produced negligible macroscopic injury and failed to influence GBF significantly compared to the injuries recorded in vehicle-controlled rats. Single and repeated (5 times) administration of HP LPS significantly reduced ethanol- and WRS-induced lesions, these protective effects were accompanied by a rise in GBF and excessive luminal release of NO. The suppression of NOS activity by L-NAME (20 mg/kg i.p.), a nonspecific NOS inhibitor, or L- (30 mg/kg i.g.), a specific iNOS inhibitor, and of COX-2 activity by NS-398 reversed the protective and hyperemic effects of single or repeated LPS administrations against ethanol and WRS damage and the accompanying rise in NO and PGE2 production. These effects of L-NAME were significantly antagonized by the addition of L-arginine, a substrate for NO synthesis. The signals for cNOS, COX-1 and HSP 70 mRNA were detected by RT-PCR in the vehicle-treated gastric mucosa, whereas gene and protein expression of iNOS, COX-2 and HSP 70 mRNA were significantly increased only in rats treated with 1 or 5 applications of HP LPS. Conclusions: Repeated injections of HP LPS enhance gastric mucosal resistance to the mucosal damage induced by ethanol and WRS via a mechanism involving mucosal overexpression of iNOS, COX-2 and HSP 70 with subsequent excessive production of NO and PGE2.


Growth Hormone & Igf Research | 2009

Involvement of sensory nerves in the protective effect of growth hormone on acute pancreatitis

Jolanta Jaworek; Anna Leja-Szpak; Dembiński A; Tomaszewska R; Joanna Szklarczyk; Michalina Kot; Katarzyna Nawrot-Porąbka; Bonior J; Warzecha Z; Pawlik Ww

UNLABELLEDnGrowth hormone (GH) has been shown to protect the intestinal barrier integrity and to stimulate the production of insulin-like growth factor 1 (IGF-1), which inhibits the development of acute pancreatitis. Sensory nerves are implicated in the protection of pancreatic tissue against acute inflammation. The aim of this study was to investigate the influence of exogenous GH on acute pancreatitis (AP) and to assess the involvement of sensory nerves and IGF-1 in above effect. Studies were performed on Wistar rats. AP was induced by subcutaneous administration of caerulein (25mug/kg) to the conscious animals. GH (1 or 2mg/kg) was administered to the rats as an intraperitoneal injection 30min prior to the start of AP. To deactivate sensory nerves capsaicin was given at total dose of 100mg/kg 10days before the experiments. AP was confirmed by histological examination and manifested by the significant rises of pancreatic weight, and serum activities of lipase, TNFalpha and IL-10 (by 550%, 300% and 50%, respectively), whereas IGF-1 blood concentration was markedly reduced. Administration of GH prior to the caerulein infusion significantly increased GH, IGF-1 and IL-10 blood levels, attenuated harmful effects of AP and reduced histological manifestations of pancreatitis in the rats with intact sensory nerves. This was accompanied by the reduction of serum lipase, and TNFalpha activities. In the AP rats with capsaicin-deactivated sensory nerves GH failed to protect the pancreas against acute damage and, as a consequence of above deactivation, IGF-1 was low.nnnCONCLUSIONnGH modulates the development of acute pancreatitis in the presence of active sensory nerves probably via stimulation of IGF-1 release.


Journal of Physiology and Pharmacology | 2007

Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT).

Konturek Sj; Konturek Pc; Brzozowska I; Pawlik Mw; Zbigniew Sliwowski; Marta Czesnikiewicz-Guzik; Kwiecień S; Brzozowski T; G. A. Bubenik; Pawlik Ww


Journal of Physiology and Pharmacology | 2008

PROTECTIVE AND THERAPEUTIC EFFECT OF HEPARIN IN ACUTE PANCREATITIS

Piotr Ceranowicz; Dembiński A; Warzecha Z; Marcin Dembiński; Jakub Cieszkowski; K. Rembiasz; Konturek Sj; Kusnierz-Cabala B; Tomaszewska R; Pawlik Ww


Journal of Physiology and Pharmacology | 2008

THE EFFECT OF ENDURANCE TRAINING ON MUSCLE STRENGTH IN YOUNG, HEALTHY MEN IN RELATION TO HORMONAL STATUS

Brzozowski T; Konturek Pc; Pajdo R; Agata Ptak-Belowska; Kwiecień S; Pawlik Mw; Drozdowicz D; Zbigniew Sliwowski; Bartosz Brzozowski; Konturek Sj; Pawlik Ww


Journal of Physiology and Pharmacology | 2006

Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with helicobacter pylori in the stomach of humans and experimental animals

T. Brzozowski; Konturek Pc; Zbigniew Sliwowski; Kwiecień S; Drozdowicz D; Pawlik Mw; K Mach; Konturek Sj; Pawlik Ww

Collaboration


Dive into the Pawlik Ww's collaboration.

Top Co-Authors

Avatar

Konturek Sj

Jagiellonian University Medical College

View shared research outputs
Top Co-Authors

Avatar

Brzozowski T

New York Academy of Medicine

View shared research outputs
Top Co-Authors

Avatar

Pawlik Mw

Jagiellonian University Medical College

View shared research outputs
Top Co-Authors

Avatar

Kwiecień S

Jagiellonian University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dembiński A

Jagiellonian University

View shared research outputs
Top Co-Authors

Avatar

Jaworek J

Jagiellonian University Medical College

View shared research outputs
Top Co-Authors

Avatar

Warzecha Z

Jagiellonian University

View shared research outputs
Top Co-Authors

Avatar

Konturek Pc

University of Erlangen-Nuremberg

View shared research outputs
Top Co-Authors

Avatar

Piotr Ceranowicz

Jagiellonian University Medical College

View shared research outputs
Researchain Logo
Decentralizing Knowledge